{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:54:05Z","timestamp":1791143645186,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bj.2026.101043","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:24:17Z","timestamp":1791041057000},"page":"101043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Landscape of Microbiome Modulators in Gynecological Tumor Treatment: From Pre-Clinical to Clinical Trials"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1897-7120","authenticated-orcid":false,"given":"Jiaxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-9724","authenticated-orcid":false,"given":"Sunlu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2026.101043_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2221093","article-title":"Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway","volume":"15","author":"Hu","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bj.2026.101043_bib2","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3390\/cells11193038","article-title":"Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota","volume":"11","author":"Prakash","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bj.2026.101043_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216584","article-title":"Magnolin targeting of the JNK\/Sp1\/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation","volume":"583","author":"Lin","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bj.2026.101043_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.semcancer.2021.07.013","article-title":"Microbes in gynecologic cancers: Causes or consequences and therapeutic potential","volume":"86","author":"Wahid","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bj.2026.101043_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen gut microbiome axis: Physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.bj.2026.101043_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/nu12020457","article-title":"Flavonoids as Anticancer Agents","volume":"12","author":"Kopustinskiene","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bj.2026.101043_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107973","article-title":"The gut microbiome and efficacy of cancer immunotherapy","volume":"231","author":"Roviello","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bj.2026.101043_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2022.0494","article-title":"The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm","volume":"8","author":"Liu","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bj.2026.101043_bib9","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.3098","article-title":"First-in-class microbial ecosystem therapeutics 4 (MET4) in metastatic solid cancer patients treated with immunotherapy: MET4-IO","volume":"38","author":"Araujo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bj.2026.101043_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.3145","article-title":"Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naive patients with cancer: Updated safety data","volume":"41","author":"Lythgoe","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bj.2026.101043_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1590","article-title":"Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer","volume":"6","author":"Dong","year":"2020","journal-title":"Sci. Adv."}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417026000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417026000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:16:10Z","timestamp":1791141370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417026000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":11,"alternative-id":["S2319417026000995"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2026.101043","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Landscape of Microbiome Modulators in Gynecological Tumor Treatment: From Pre-Clinical to Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2026.101043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"101043"}}